2,410
Views
68
CrossRef citations to date
0
Altmetric
Review Article

Drugs interfering with mitochondrial disorders

&
Pages 138-151 | Received 06 Apr 2009, Accepted 24 Jul 2009, Published online: 19 Oct 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Michał Nowak, Katarzyna Królak-Nowak, Aleksandra Sobolewska-Włodarczyk, Jakub Fichna & Marcin Włodarczyk. (2016) Elevated risk of venous thromboembolic events in patients with inflammatory myopathies. Vascular Health and Risk Management 12, pages 233-238.
Read now
Violeta Mihaylova, Velina Guergueltcheva, Sylvia Cherninkova, Luchezar Penev, Galina Georgieva, Katya Stoyanova, Albenaa Todorova & Ivaylo Tournev. (2013) Possible Toxicity of Tuberculostatic Agents in a Patient With a Novel TYMP Mutation Leading to Mitochondrial Neurogastrointestinal Encephalomyopathy. Journal of Neurogenetics 27:1-2, pages 19-22.
Read now
Gerald Pfeffer & Patrick F. Chinnery. (2013) Diagnosis and treatment of mitochondrial myopathies. Annals of Medicine 45:1, pages 4-16.
Read now
Michelangelo Mancuso, Daniele Orsucci, Massimiliano Filosto, Costanza Simoncini & Gabriele Siciliano. (2012) Drugs and mitochondrial diseases: 40 queries and answers. Expert Opinion on Pharmacotherapy 13:4, pages 527-543.
Read now
Dominique Pessayre, Bernard Fromenty, Alain Berson, Marie-Anne Robin, Philippe Lettéron, Richard Moreau & Abdellah Mansouri. (2012) Central role of mitochondria in drug-induced liver injury. Drug Metabolism Reviews 44:1, pages 34-87.
Read now

Articles from other publishers (63)

Auxiliare Kuretu, Charles Arineitwe, Mamosheledi Mothibe, Phikelelani Ngubane, Andile Khathi & Ntethelelo Sibiya. (2023) Drug-induced mitochondrial toxicity: Risks of developing glucose handling impairments. Frontiers in Endocrinology 14.
Crossref
Peter Biro, Dierk Vagts, Uta Emmig & Heike KaltofenDierk A. Vagts, Heike Kaltofen, Uta Emmig & Peter Biro. 2020. Anästhesie bei seltenen Erkrankungen. Anästhesie bei seltenen Erkrankungen 1 4 .
Patrizia Bottoni, Giulia Gionta & Roberto Scatena. (2022) Remarks on Mitochondrial Myopathies. International Journal of Molecular Sciences 24:1, pages 124.
Crossref
Ryan L. Davis, Kishore R. Kumar, Clare PuttickChristina Liang, Kate E. AhmadFabienne Edema-HildebrandJin-Sung ParkAndre E. MinocheVelimir GayevskiyAmali C. Mallawaarachchi, John Christodoulou, Deborah Schofield, Marcel E. Dinger, Mark J. Cowley & Carolyn M. Sue. (2022) Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis. Neurology 99:7.
Crossref
Regina Pawlak-Chomicka, Tomasz Krauze, Pawel Uruski, Jaroslaw Piskorski, Andrzej Wykretowicz, Andrzej Tykarski & Przemyslaw Guzik. (2022) The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension. Cardiology Research and Practice 2022, pages 1-9.
Crossref
Hok-Fung Tong, Han-Chih Hencher Lee, Tsz-Yan Tammy Tong, Siu-Fung Lam, Bun Sheng, Kin-Wah Chan, June Kam-Yin Li, Ho-Kee Vicki Tam & Chor-Kwan Ching. (2022) Neurological manifestations in m.3243A>G-related disease triggered by metformin. Journal of Diabetes and its Complications 36:3, pages 108111.
Crossref
Jingfeng Han, Weiping Tao, Wei Cui & Jiawei Chen. (2022) Propofol via Antioxidant Property Attenuated Hypoxia-Mediated Mitochondrial Dynamic Imbalance and Malfunction in Primary Rat Hippocampal Neurons. Oxidative Medicine and Cellular Longevity 2022, pages 1-16.
Crossref
Ji-Hoon Na, Min Jung Lee, Chul Ho Lee & Young-Mock Lee. (2021) Association Between Epilepsy and Leigh Syndrome With MT-ND3 Mutation, Particularly the m.10191T>C Point Mutation. Frontiers in Neurology 12.
Crossref
Takeshi Tokuyama, Razan Elfadil Ahmed, Nawin Chanthra, Tatsuya Anzai & Hideki Uosaki. (2021) Disease Modeling of Mitochondrial Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells. Biology 10:10, pages 981.
Crossref
Ryan Atkins, Dumitru Constantin-Teodosiu, Krishna K. Varadhan, Despina Constantin, Dileep N. Lobo & Paul L. Greenhaff. (2021) Major elective abdominal surgery acutely impairs lower limb muscle pyruvate dehydrogenase complex activity and mitochondrial function. Clinical Nutrition 40:3, pages 1046-1051.
Crossref
Chad A. Bousman, Susanne A. Bengesser, Katherine J. Aitchison, Azmeraw T. Amare, Harald Aschauer, Bernhard T. Baune, Bahareh Behroozi Asl, Jeffrey R. Bishop, Margit Burmeister, Boris Chaumette, Li-Shiun Chen, Zachary A. Cordner, Jürgen Deckert, Franziska Degenhardt, Lynn E. DeLisi, Lasse Folkersen, James L. Kennedy, Teri E. Klein, Joseph L. McClay, Francis J. McMahon, Richard Musil, Nancy L. Saccone, Katrin Sangkuhl, Robert M. Stowe, Ene-Choo Tan, Arun K. Tiwari, Clement C. Zai, Gwyneth Zai, Jianping Zhang, Andrea Gaedigk & Daniel J Müller. (2020) Review and Consensus on Pharmacogenomic Testing in Psychiatry. Pharmacopsychiatry 54:01, pages 5-17.
Crossref
Castanares-Zapatero Diego & Hantson Philippe. 2021. Mitochondrial Dysfunction and Nanotherapeutics. Mitochondrial Dysfunction and Nanotherapeutics 203 220 .
Daniele Orsucci, Elena Caldarazzo Ienco, Gabriele Siciliano & Michelangelo Mancuso. 2021. Clinical Bioenergetics. Clinical Bioenergetics 509 532 .
Yunyi Yao & David A. Lawrence. (2020) Susceptibility to COVID‐19 in populations with health disparities: Posited involvement of mitochondrial disorder, socioeconomic stress, and pollutants. Journal of Biochemical and Molecular Toxicology 35:1.
Crossref
Maxim Jestin, Senta M. Kapnick, Tatyana N. Tarasenko, Cassidy T. Burke, Patricia M. Zerfas, Francisca Diaz, Hilary Vernon, Larry N. Singh, Ronald J. Sokol & Peter J. McGuire. (2020) Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity. Molecular Metabolism 37, pages 100981.
Crossref
Andreas C. Blank, Johannes M. P. J. Breur, Sabine A. Fuchs, Klaas Koop & Annette F. Baas. 2020. Clinical Cardiogenetics. Clinical Cardiogenetics 179 190 .
Wei Jiang, Chao Zhang, Arsalan Ahmed, Yunlei Zhao, Yu Deng, Yin Ding, Jianfeng Cai & Yong Hu. (2019) H 2 O 2 ‐Sensitive Upconversion Nanocluster Bomb for Tri‐Mode Imaging‐Guided Photodynamic Therapy in Deep Tumor Tissue . Advanced Healthcare Materials 8:20, pages 1900972.
Crossref
Li-Na Lee, Chun-Ta Huang, Chia-Lin Hsu, Hsiu-Ching Chang, I-Shiow Jan, Jia-Luen Liu, Jin-Chuan Sheu, Jann-Tay Wang, Wei-Lun Liu, Huei-Shu Wu, Ching-Nien Chang & Jann-Yuan Wang. (2019) Mitochondrial DNA Variants in Patients with Liver Injury Due to Anti-Tuberculosis Drugs. Journal of Clinical Medicine 8:8, pages 1207.
Crossref
Margarida Paiva Coelho, Esmeralda Martins & Laura Vilarinho. (2018) Diagnosis, management, and follow-up of mitochondrial disorders in childhood: a personalized medicine in the new era of genome sequence. European Journal of Pediatrics 178:1, pages 21-32.
Crossref
Josef Finsterer & Sinda Zarrouk-Mahjoub. (2018) Pre-eclampsia in a Parturient With MELAS. A&A Practice 10:1, pages 31.
Crossref
Alan W.C. Yuen, Mark R. Keezer & Josemir W. Sander. (2018) Epilepsy is a neurological and a systemic disorder. Epilepsy & Behavior 78, pages 57-61.
Crossref
Alan W.C. Yuen, Isabel A. Walcutt & Josemir W. Sander. (2017) An acidosis-sparing ketogenic (ASK) diet to improve efficacy and reduce adverse effects in the treatment of refractory epilepsy. Epilepsy & Behavior 74, pages 15-21.
Crossref
M. GRUNDMANOVÁ, D. JARKOVSKÁ, A. SÜß, Z. TŮMA, M. MARKOVÁ, Z. GRUNDMAN, A. EL-KADI, M. ČEDÍKOVÁ, M. ŠTENGL & J. KUNCOVÁ. (2016) Propofol-Induced Mitochondrial and Contractile Dysfunction of the Rat Ventricular Myocardium. Physiological Research, pages S601-S609.
Crossref
Jamie Bellinge, Sanjaya Herath & Dharmesh Sonigra. (2016) Sodium Valproate Exacerbating an Underlying Disorder of Fatty Acid Metabolism. Case Reports in Neurology 8:3, pages 185-192.
Crossref
Frederic Shapiro, Umeshkumar Athiraman, David J. Clendenin, Monica Hoagland & Navil F. Sethna. (2016) Anesthetic management of 877 pediatric patients undergoing muscle biopsy for neuromuscular disorders: a 20-year review. Pediatric Anesthesia 26:7, pages 710-721.
Crossref
Christina Reinauer, Thomas Meissner, Michael Roden, Angelika Thon, Paul-Martin Holterhus, Holger Haberland, Elisabeth Binder, Wolfgang Marg, Esther Bollow & Reinhard Holl. (2015) Low prevalence of patients with mitochondrial disease in the German/Austrian DPV diabetes registry. European Journal of Pediatrics 175:5, pages 613-622.
Crossref
Samantha E. Marin & Russell P. Saneto. (2016) Neuropsychiatric Features in Primary Mitochondrial Disease. Neurologic Clinics 34:1, pages 247-294.
Crossref
Bun Sheng, Man Kei Fong, Wing Kwan Ng, Sammy Pak Lam Chen & Chloe Miu Mak. (2016) MELAS, MIDD and Beyond: m.3243A>G MT-TL1 Mutation in Adult Patients. International Journal of Clinical Medicine 07:07, pages 487-495.
Crossref
Cheryl Samuels, Mary Kay Koenig, Mariana Hernandez, Aravind Yadav & Ricardo A. Mosquera. (2016) Mitochondrial Disorder Aggravated by Metoprolol. Case Reports in Pediatrics 2016, pages 1-3.
Crossref
Fernando Acebrón Sánchez-Herrera, Carla Anciones Martín, Asier de Albóniga-Chindurza Barroeta, Carlos Miguel Guirao Rubio, Paula Pérez Torre, Alicia Vives Luengo, Iñigo Corral Corral, Araceli Alonso Cánovas & Javier Ortiz Rodríguez. (2015) Utilización de haloperidol en un paciente con síndrome de encefalomiopatía mitocondrial, acidosis láctica y episodios parecidos a ictus (síndrome MELAS). Psiquiatría Biológica 22:3, pages 77-79.
Crossref
Minjun Chen, Ayako Suzuki, Jürgen Borlak, Raúl J. Andrade & M Isabel Lucena. (2015) Drug-induced liver injury: Interactions between drug properties and host factors. Journal of Hepatology 63:2, pages 503-514.
Crossref
Wadad Saba, Sébastien Goutal, Bertrand Kuhnast, Frédéric Dollé, Sylvain Auvity, Yoan Fontyn, Jérôme Cayla, Marie-Anne Peyronneau, Héric Valette & Nicolas Tournier. (2015) Differential influence of propofol and isoflurane anesthesia in a non-human primate on the brain kinetics and binding of [ 18 F]DPA-714, a positron emission tomography imaging marker of glial activation . European Journal of Neuroscience 42:1, pages 1738-1745.
Crossref
Werner Klingler & Frank Lehmann-Horn. 2015. Neuromuscular Disorders of Infancy, Childhood, and Adolescence. Neuromuscular Disorders of Infancy, Childhood, and Adolescence 913 921 .
Ulrike Schara, Christiane Schneider-Gold & Bertold SchrankB. Schrank. 2015. Klinik und Transition neuromuskulärer Erkrankungen. Klinik und Transition neuromuskulärer Erkrankungen 187 193 .
Luca Iaccarino, Elena Bartoloni, Roberto Gerli, Alessia Alunno, Simone Barsotti, Giacomo Cafaro, Mariele Gatto, Rosaria Talarico, Alessandra Tripoli, Margherita Zen, Rossella Neri & Andrea Doria. (2014) Drugs in induction and treatment of idiopathic inflammatory myopathies. Autoimmunity Highlights 5:3, pages 95-100.
Crossref
Helena Torrell, Antonio Salas, Nerea Abasolo, Constanza Morén, Glòria Garrabou, Joaquín Valero, Yolanda Alonso, Elisabet Vilella, Javier Costas & Lourdes Martorell. (2014) Mitochondrial DNA (mtDNA) variants in the European haplogroups HV, JT, and U do not have a major role in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 165:7, pages 607-617.
Crossref
J.J. Rahn, J.E. Bestman, B.J. Josey, E.S. Inks, K.D. Stackley, C.E. Rogers, C.J. Chou & S.S.L. Chan. (2014) Novel Vitamin K analogs suppress seizures in zebrafish and mouse models of epilepsy. Neuroscience 259, pages 142-154.
Crossref
Sumit Parikh, Amy Goldstein, Mary Kay Koenig, Fernando Scaglia, Gregory M. Enns, Russell Saneto, Irina Anselm, Abigail Collins, Bruce H. Cohen, Suzanne D. DeBrosse, David Dimmock, Marni J. Falk, Jaya Ganesh, Carol Greene, Andrea L. Gropman, Richard Haas, Stephen G. Kahler, John Kamholz, Fran Kendall, Mark S. Korson, Andre Mattman, Margherita Milone, Dmitriy Niyazov, Phillip L. Pearl, Tyler Reimschisel, Ramona Salvarinova-Zivkovic, Katherine Sims, Mark Tarnopolsky, Chang-Yong Tsao, Johan van Hove, Laurence Walsh & Lynne A. Wolfe. (2013) Practice patterns of mitochondrial disease physicians in North America. Part 2: treatment, care and management. Mitochondrion 13:6, pages 681-687.
Crossref
Manuela G. Neuman, Radu M. Nanau, Tawfeeq Shekh-Ahmad, Boris Yagen & Meir Bialer. (2013) Valproic acid derivatives signal for apoptosis and repair in vitro. Clinical Biochemistry 46:15, pages 1532-1537.
Crossref
Radu M. Nanau & Manuela G. Neuman. (2013) Adverse drug reactions induced by valproic acid. Clinical Biochemistry 46:15, pages 1323-1338.
Crossref
Julie Massart, Karima Begriche, Nelly Buron, Mathieu Porceddu, Annie Borgne-Sanchez & Bernard Fromenty. (2013) Drug-Induced Inhibition of Mitochondrial Fatty Acid Oxidation and Steatosis. Current Pathobiology Reports 1:3, pages 147-157.
Crossref
Eleonora Aronica & Werner Stenzel. 2013. Muscle Disease. Muscle Disease 328 338 .
Joel N. Meyer, Maxwell C. K. Leung, John P. Rooney, Ataman Sendoel, Michael O. Hengartner, Glen E. Kisby & Amanda S. Bess. (2013) Mitochondria as a Target of Environmental Toxicants. Toxicological Sciences 134:1, pages 1-17.
Crossref
Anna Olszewska & Adam Szewczyk. (2013) Mitochondria as a pharmacological target: Magnum overview. IUBMB Life 65:3, pages 273-281.
Crossref
Martin Windpessl & Petra M^|^uuml;ller. (2013) Valproic Acid and MELAS: A Word of Warning. Internal Medicine 52:9, pages 1011-1011.
Crossref
Fady Hannah-Shmouni, Sandra Sirrs, Michelle M. Mezei, Paula J. Waters & Andre Mattman. 2014. JIMD Reports - Volume 12. JIMD Reports - Volume 12 17 23 .
Kwang H. Choi, Thien Le, Jennifer McGuire, Jennifer Coyner, Brandon W. Higgs, Suad Diglisic, Luke R. Johnson, David M. Benedek & Robert J. Ursano. (2012) Expression Profiles of Mitochondrial Genes in the Frontal Cortex and the Caudate Nucleus of Developing Humans and Mice Selectively Bred for High and Low Fear. PLoS ONE 7:11, pages e49183.
Crossref
Werner J H Koopman, Felix Distelmaier, Jan AM Smeitink & Peter HGM Willems. (2012) OXPHOS mutations and neurodegeneration. The EMBO Journal 32:1, pages 9-29.
Crossref
N. Weiss & B. Eymard. (2012) Maladies musculaires en réanimation. Quand les évoquer ? Comment orienter la recherche diagnostique ?Muscular disease in ICU. When should they be evoked? How to advance in the diagnosis?. Réanimation 21:5, pages 583-605.
Crossref
J. Finsterer. (2012) Cognitive dysfunction in mitochondrial disorders. Acta Neurologica Scandinavica 126:1, pages 1-11.
Crossref
A. V. VANLANDER, P. G. JORENS, J. SMET, B. DE PAEPE, W. VERBRUGGHE, G. G. VAN DEN EYNDEN, F. MEIRE, P. PAUWELS, N. VAN DER AA, S. SENECA, W. LISSENS, J. G. OKUN & R. VAN COSTER. (2012) Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome. Acta Anaesthesiologica Scandinavica 56:4, pages 520-525.
Crossref
Werner J.H. Koopman, Peter H.G.M. Willems & Jan A.M. Smeitink. (2012) Monogenic Mitochondrial Disorders. New England Journal of Medicine 366:12, pages 1132-1141.
Crossref
F. L. Mastaglia & M. Needham. (2011) Update on Toxic Myopathies. Current Neurology and Neuroscience Reports 12:1, pages 54-61.
Crossref
Peggy Roestenberg, Ganesh R. Manjeri, Federica Valsecchi, Jan A.M. Smeitink, Peter H.G.M. Willems & Werner J.H. Koopman. (2012) Pharmacological targeting of mitochondrial complex I deficiency: The cellular level and beyond. Mitochondrion 12:1, pages 57-65.
Crossref
J. Lerman. (2011) Perioperative management of the paediatric patient with coexisting neuromuscular disease. British Journal of Anaesthesia 107, pages i79-i89.
Crossref
Alan W.C. Yuen & Josemir W. Sander. (2011) Impaired mitochondrial energy production: The basis of pharmacoresistance in epilepsy. Medical Hypotheses 77:4, pages 536-540.
Crossref
Hsiu-Fen Lee, Ching-Shiang Chi, Chi-Ren Tsai & Chin-Hsuan Chen. (2011) Epileptic Seizures in Infants and Children With Mitochondrial Diseases. Pediatric Neurology 45:3, pages 169-174.
Crossref
Ann Gardner & Richard G. Boles. (2011) Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:3, pages 730-743.
Crossref
Karima Begriche, Julie Massart, Marie-Anne Robin, Annie Borgne-Sanchez & Bernard Fromenty. (2011) Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver. Journal of Hepatology 54:4, pages 773-794.
Crossref
J. Finsterer. (2011) Treatment of central nervous system manifestations in mitochondrial disorders. European Journal of Neurology 18:1, pages 28-38.
Crossref
Peter Biro, Dierk A. Vagts, Uta Emmig & Thomas PaschPeter Biro, Dierk A. Vagts, Uta Emmig & Thomas Pasch. 2011. Anästhesie bei seltenen Erkrankungen. Anästhesie bei seltenen Erkrankungen 155 186 .
Josef Finsterer & Peter Barton. (2011) Regression of stroke-like lesions in MELAS-syndrome after seizure control. Epileptic Disorders 12:4, pages 330-334.
Crossref
I. O. Mazunin, N. V. Volodko, E. B. Starikovskaya & R. I. Sukernik. (2010) Mitochondrial genome and human mitochondrial diseases. Molecular Biology 44:5, pages 665-681.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.